0001375151-21-000023.txt : 20210317
0001375151-21-000023.hdr.sgml : 20210317
20210317160420
ACCESSION NUMBER: 0001375151-21-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210315
FILED AS OF DATE: 20210317
DATE AS OF CHANGE: 20210317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galer Bradley S.
CENTRAL INDEX KEY: 0001594565
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 21750558
MAIL ADDRESS:
STREET 1: C/O ZOGENIX, INC.
STREET 2: 12400 HIGH BLUFF DR., SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 500
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 500
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_161601144117165.xml
FORM 4
X0306
4
2021-03-15
0
0001375151
ZOGENIX, INC.
ZGNX
0001594565
Galer Bradley S.
C/O ZOGENIX, INC.
5959 HORTON STREET, SUITE 500
EMERYVILLE
CA
94608
0
1
0
0
EVP/Chief Medical Officer
Common Stock
2021-03-15
4
M
0
1562
0
A
19609
D
Common Stock
2021-03-15
4
F
0
438
20.70
D
19171
D
Common Stock
2021-03-15
4
M
0
2031
0
A
21202
D
Common Stock
2021-03-15
4
F
0
569
20.70
D
20633
D
Common Stock
2021-03-15
4
M
0
1625
0
A
22258
D
Common Stock
2021-03-15
4
F
0
455
20.70
D
21803
D
Restricted Stock Units
2021-03-15
4
M
0
1562
0
D
Common Stock
1562.0
1562
D
Restricted Stock Units
2021-03-15
4
M
0
2031
0
D
Common Stock
2031.0
4062
D
Restricted Stock Units
2021-03-15
4
M
0
1625
0
D
Common Stock
1625.0
4875
D
Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018.
Includes 845 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person.
Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 1.
Represents vesting of one-fourth (1/4) of restricted stock units granted on March 22, 2019.
Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 4.
Represents vesting of one-fourth (1/4) of restricted stock units granted on March 4, 2020.
Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 6.
Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock.
The restricted stock units vests in four equal installments on each of March 15, 2019, 2020, 2021 and 2022, subject to the reporting person's continuous service to the Company on such vesting date.
Not applicable.
The restricted stock units vests in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date.
The restricted stock units vests in four equal installments on each of March 15, 2021, 2022, 2023 and 2024, subject to the reporting person's continuous service to the Company on such vesting date.
/s/ Thomas Doyle, Attorney-in-fact for Bradley Galer
2021-03-17